Vincristine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Vincristine and local guidelines before prescribing.

Vinca alkaloid cytotoxic

Mechanism

Vinca alkaloid binding tubulin.

Uses

Acute leukaemia, lymphoma, paediatric tumours.

Dosing

Side effects

Peripheral neuropathy, constipation, ileus, SIADH, severe tissue damage if extravasated.

Interactions

CYP3A4 inhibitors (azoles) increase neurotoxicity.

Contraindications and cautions

Demyelinating neuropathy

Monitoring

Neurological exam, FBC, LFT

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose in hepatic impairment

Overdose and reversal

Supportive

Special advice

Intravenous only; fatal if given intrathecally; laxatives with treatment.

More from the textbook: uses, cautions and other points
Where it is discussed in the book